Grunblatt E - Search Results

1

Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.

Mandel S, Grunblatt E, Riederer P, Amariglio N, Jacob-Hirsch J, Rechavi G, Youdim MB. Mandel S, et al. Among authors: grunblatt e. Ann N Y Acad Sci. 2005 Aug;1053:356-75. doi: 10.1196/annals.1344.031. Ann N Y Acad Sci. 2005. PMID: 16179542 Review.

2

Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity.

Grünblatt E, Mandel S, Gassen M, Youdim MB. Grünblatt E, et al. J Neural Transm Suppl. 1999;55:57-70. doi: 10.1007/978-3-7091-6369-6_6. J Neural Transm Suppl. 1999. PMID: 10335493 Review.

3

Apomorphine protects against MPTP-induced neurotoxicity in mice.

Grünblatt E, Mandel S, Berkuzki T, Youdim MB. Grünblatt E, et al. Mov Disord. 1999 Jul;14(4):612-8. doi: 10.1002/1531-8257(199907)14:4<612::aid-mds1010>3.0.co;2-6. Mov Disord. 1999. PMID: 10435498

4

The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators.

Youdim MB, Grünblatt E, Mandel S. Youdim MB, et al. Among authors: grunblatt e. Ann N Y Acad Sci. 1999;890:7-25. doi: 10.1111/j.1749-6632.1999.tb07977.x. Ann N Y Acad Sci. 1999. PMID: 10668410

5

Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP.

Grünblatt E, Mandel S, Youdim MB. Grünblatt E, et al. Ann N Y Acad Sci. 2000;899:262-73. doi: 10.1111/j.1749-6632.2000.tb06192.x. Ann N Y Acad Sci. 2000. PMID: 10863545 Review.

6

MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies.

Grünblatt E, Mandel S, Youdim MB. Grünblatt E, et al. J Neurol. 2000 Apr;247 Suppl 2:II95-102. doi: 10.1007/pl00022909. J Neurol. 2000. PMID: 10991672 Review.

7

Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine.

Youdim MB, Gassen M, Gross A, Mandel S, Grünblatt E. Youdim MB, et al. Among authors: grunblatt e. J Neural Transm Suppl. 2000;(58):83-96. doi: 10.1007/978-3-7091-6284-2_7. J Neural Transm Suppl. 2000. PMID: 11128615 Review.

8

cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6-hydroxydopamine models: implications for idiopathic Parkinson's disease.

Mandel S, Grünblatt E, Youdim M. Mandel S, et al. Among authors: grunblatt e. J Neural Transm Suppl. 2000;(60):117-24. doi: 10.1007/978-3-7091-6301-6_7. J Neural Transm Suppl. 2000. PMID: 11205134

9

Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss.

Grünblatt E, Mandel S, Maor G, Youdim MB. Grünblatt E, et al. J Neurochem. 2001 Apr;77(1):146-56. doi: 10.1046/j.1471-4159.2001.t01-1-00227.x. J Neurochem. 2001. PMID: 11279270 Free article.

10

Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine.

Grünblatt E, Mandel S, Maor G, Youdim MB. Grünblatt E, et al. J Neurochem. 2001 Jul;78(1):1-12. doi: 10.1046/j.1471-4159.2001.00397.x. J Neurochem. 2001. PMID: 11432968 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters